Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

MERS-CoV Standards, Assays and Animal Models for Vaccine Development Landscape Analysis Coalition for Epidemic Preparedness Innovations 2

Autor: Tsvetnitsky, Vadim, Price, Albert, Sayeed, Eddy, Sizemore, Donata, Gieber, Lisa, Youngdahl, Karie, Holst, Johan, Román, Raúl Gómez, Clark, Carolyn, Kristiansen, Paul A, Shurtleff, Amy, Bernasconi, Valentina, Celine Gurry, 王瑞荣 Amy

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5308baaa8491eb91bf76e705b3c744cb

Correction to: Developing vaccines against epidemic-prone emerging infectious diseases.

Autor: Bernasconi, Valentina, Kristiansen, Paul A., Whelan, Mike, Román, Raúl Gómez, Bettis, Alison, Yimer, Solomon Abebe, Gurry, Céline, Andersen, Svein R., Yeskey, Debra, Mandi, Henshaw, Kumar, Arun, Holst, Johan, Clark, Carolyn, Cramer, Jakob P., Røttingen, John-Arne, Hatchett, Richard, Saville, Melanie, Norheim, Gunnstein

Publikováno v: Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz; Feb2020, Vol. 63 Issue 2, p226-226, 1p

Developing vaccines against epidemic-prone emerging infectious diseases.

Autor: Bernasconi V; Coalition for Epidemic Preparedness Innovation (CEPI), Marcus Thranes Gate 2, 0473, Oslo, Norway., Kristiansen PA; Coalition for Epidemic Preparedness Innovation (CEPI), Marcus Thranes Gate 2, 0473, Oslo, Norway., Whelan M; Coalition for Epidemic Preparedness Innovation (CEPI), NW1 2BE, London, UK., Román RG; Coalition for Epidemic Preparedness Innovation (CEPI), Marcus Thranes Gate 2, 0473, Oslo, Norway., Bettis A; Coalition for Epidemic Preparedness Innovation (CEPI), Marcus Thranes Gate 2, 0473, Oslo, Norway., Yimer SA; Coalition for Epidemic Preparedness Innovation (CEPI), Marcus Thranes Gate 2, 0473, Oslo, Norway., Gurry C; Coalition for Epidemic Preparedness Innovation (CEPI), Marcus Thranes Gate 2, 0473, Oslo, Norway., Andersen SR; Coalition for Epidemic Preparedness Innovation (CEPI), Marcus Thranes Gate 2, 0473, Oslo, Norway., Yeskey D; Coalition for Epidemic Preparedness Innovation (CEPI), Washington, DC, USA., Mandi H; Coalition for Epidemic Preparedness Innovation (CEPI), Marcus Thranes Gate 2, 0473, Oslo, Norway., Kumar A; Coalition for Epidemic Preparedness Innovation (CEPI), Marcus Thranes Gate 2, 0473, Oslo, Norway., Holst J; Coalition for Epidemic Preparedness Innovation (CEPI), Marcus Thranes Gate 2, 0473, Oslo, Norway., Clark C; Coalition for Epidemic Preparedness Innovation (CEPI), Marcus Thranes Gate 2, 0473, Oslo, Norway., Cramer JP; Coalition for Epidemic Preparedness Innovation (CEPI), NW1 2BE, London, UK., Røttingen JA; Coalition for Epidemic Preparedness Innovation (CEPI), Marcus Thranes Gate 2, 0473, Oslo, Norway.; Research Council of Norway, Lysaker, Norway., Hatchett R; Coalition for Epidemic Preparedness Innovation (CEPI), Marcus Thranes Gate 2, 0473, Oslo, Norway., Saville M; Coalition for Epidemic Preparedness Innovation (CEPI), NW1 2BE, London, UK., Norheim G; Coalition for Epidemic Preparedness Innovation (CEPI), Marcus Thranes Gate 2, 0473, Oslo, Norway. gunnstein.norheim@cepi.net.

Publikováno v: Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz [Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz] 2020 Jan; Vol. 63 (1), pp. 65-73.